CYP2A7

CYP2A7 is a member of the cytochrome P450 superfamily of enzymes. These enzymes are a group of heme-thiolate monooxygenases that are involved in the metabolism of a wide variety of substrates, including xenobiotics, fatty acids, and steroids. CYP2A7, specifically, is a member of the CYP2A subfamily.

Function

CYP2A7 is primarily expressed in the liver, where it plays a crucial role in the metabolism of drugs and other xenobiotics. It is also involved in the metabolism of endogenous compounds, such as fatty acids and steroids. The enzyme is known to metabolize nicotine, a major component of tobacco smoke, into cotinine.

Genetic Variation

Several genetic variants of CYP2A7 have been identified, which can affect the enzyme's activity and, consequently, an individual's ability to metabolize certain drugs. These genetic variations can lead to differences in drug response among individuals, including differences in drug efficacy and the risk of adverse drug reactions.

Clinical Significance

Given its role in drug metabolism, CYP2A7 is of significant clinical interest. Variations in the CYP2A7 gene can affect the efficacy and safety of certain drugs, making it a potential target for personalized medicine. Furthermore, because of its role in nicotine metabolism, CYP2A7 is also of interest in the study of nicotine addiction and smoking-related diseases.

See Also

• Cytochrome P450
• Drug metabolism
• Personalized medicine
• Nicotine addiction

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian